The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. T follicular helper (Tfh) cells are CD4+ T cells specialized in providing help to B cells, particularly within germinal centers (GCs). With Tfh cells delivering help signals via costimulatory molecules and cytokines, B cells undergo somatic hypermutation and affinity maturation within GCs, generating plasma cells and memory B cells and with greater protective efficacy. Tfh cells are also found in great abundance in peripheral blood of patients with systemic lupus erythematosus and myasthenia gravis, suggesting a role of Tfh cells in pathogenic autoantibody production. Therefore, increasing our knowledge of Tfh cell development and function in normal and aberrant immune responses will aid design of more efficacious vaccines against infectious diseases and discovery of novel therapeutic approaches to treat autoimmunity. Tcf1 and Lef1 transcription factors are essential for normal T cell development and are known to interact with the ?-catenin coactivator for gene regulation. Previously we showed Tcf1 and Lef1 critically regulate longevity and maturation of memory CD8+ T cells. We conditionally ablated both genes in mature T cells to bypass the impact on thymocyte development, and showed Tcf1 and Lef1 are also essential for Tfh differentiation. Our recent ChIPseq mapping of the Tcf1 cistrome in Tfh cells revealed it is broadly associated with the Tfh genetic program, beyond the reported Bcl6-Blimp1 axis. We also made a surprising finding that Tcf1 and Lef1 are not only transcriptional regulators but also have intrinsic histone deacetylase (HDAC) activity. These unexpected findings led us to hypothesize that Tcf1 and Lef1 couple the intrinsic HDAC activity with their ?-catenin- and DNA-binding capacity to shape the enhancer landscape, transcriptional programs, and functionality of Tfh cells.
Our specific aims are:
Specific Aim 1. To determine how Tcf1 and Lef1 control enhancer organization and transcriptional programming during effector Tfh differentiation..
Specific Aim 2. To investigate the necessity and sufficiency of ?-catenin pathway in Tfh differentiation. This application will use viral infection models to systematically investigate Tcf1/Lef1 transcription factors, ?-catenin coactivator, and their interaction as novel regulators of Tfh differentiation at the initiation, effector and memory phases. It is particularly exciting that Tcf1 and Lef1 directly bridge transcriptional and epigenetic regulation in Tfh cells, which will establish a new paradigm in coordination of genetic and epigenetic regulation. These studies will thus provide rationales for utilizing the Tcf1/Lef1-?-catenin pathway to enhance Tfh functions for more effective vaccines or to dampen Tfh activities for treating autoimmune diseases.

Public Health Relevance

The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. Follicular helper T (Tfh) cells are critical for helping B cells to produce high affinity antibodies in response to a wide variety of pathogens. This project will investigate the regulatory roles of Tcf1 and Lef1 transcription factors and their coactivator ?-catenin in regulating Tfh differentiation at the initiation, effector, and memory phases. The proposed studies will provide rationales for utilizing the Tcf1/Lef1-?-catenin pathway to enhance Tfh functions for more effective vaccines or to dampen Tfh activities for treating autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI121080-03
Application #
9489059
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Ferguson, Stacy E
Project Start
2016-06-01
Project End
2021-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Iowa
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kai, Yan; Andricovich, Jaclyn; Zeng, Zhouhao et al. (2018) Predicting CTCF-mediated chromatin interactions by integrating genomic and epigenomic features. Nat Commun 9:4221
Li, Fengyin; Zeng, Zhouhao; Xing, Shaojun et al. (2018) Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun 9:5452
Andricovich, Jaclyn; Perkail, Stephanie; Kai, Yan et al. (2018) Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. Cancer Cell 33:512-526.e8
Xiu, Yan; Dong, Qianze; Li, Qingchang et al. (2018) Stabilization of NF-?B-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia. Cell Rep 22:350-358
Xing, Shaojun; Shao, Peng; Li, Fengyin et al. (2018) Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. J Exp Med 215:2211-2226
Xu, Zhe; Xing, Shaojun; Shan, Qiang et al. (2017) Cutting Edge: ?-Catenin-Interacting Tcf1 Isoforms Are Essential for Thymocyte Survival but Dispensable for Thymic Maturation Transitions. J Immunol 198:3404-3409
Li, Fengyin; He, Bing; Ma, Xiaoke et al. (2017) Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Cell Stem Cell 21:359-373.e5
Gullicksrud, Jodi A; Li, Fengyin; Xing, Shaojun et al. (2017) Differential Requirements for Tcf1 Long Isoforms in CD8+ and CD4+ T Cell Responses to Acute Viral Infection. J Immunol 199:911-919
Nish, Simone A; Zens, Kyra D; Kratchmarov, Radomir et al. (2017) CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med 214:39-47
Thapa, Puspa; Manso, Bryce; Chung, Ji Young et al. (2017) The differentiation of ROR-?t expressing iNKT17 cells is orchestrated by Runx1. Sci Rep 7:7018

Showing the most recent 10 out of 15 publications